Training with COPD: what is possible and how can you stay active?

What is COPD?

COPD stands for chronic obstructive pulmonary disease. The airways and, in some people, the alveoli are permanently damaged, restricting airflow and making it harder to empty the lungs fully (Agustí et al., 2023).

COPD may include features of chronic bronchitis and emphysema. Chronic bronchitis involves persistent airway symptoms with cough and sputum. In emphysema, alveolar walls are damaged and the lungs lose elasticity, which can trap air (GOLD, 2026).

Common symptoms include breathlessness, persistent cough, sputum, wheeze, fatigue and reduced exercise tolerance. Diagnosis should be confirmed with spirometry because symptoms alone do not reliably distinguish COPD from other causes of breathlessness (Agustí et al., 2023).

What does exacerbation mean?

Exacerbation is the medical term for a sudden worsening of COPD symptoms. In everyday language it is often called a flare-up or lung attack. Breathlessness and/or cough and sputum worsen clearly over no more than about fourteen days (Celli et al., 2021).

A flare-up may be triggered by a respiratory infection, air pollution or other inflammatory stressors. Additional bronchodilators, corticosteroids, antibiotics or hospital treatment may be required, depending on cause and severity (Celli et al., 2021) (GOLD, 2026).

A flare-up is more than an ordinary bad day. After a severe event, capacity can fall substantially and may need to be rebuilt in a controlled way (Rochester et al., 2023).

COPD does not progress identically in everyone

COPD is often called progressive, but it does not follow one straight downward line in every person. Some remain stable for long periods, whereas others lose lung function more rapidly, experience more flare-ups or develop greater limitations (Agustí et al., 2023) (GOLD, 2026).

Symptoms are not determined by one lung-function value alone. Strength, fitness, body weight, comorbidities, previous flare-ups, fear of breathlessness and daily activity also influence function (GOLD, 2026).

Exercise therefore needs to be prescribed for the whole person rather than for a spirometry number alone (Rochester et al., 2023).

The breathlessness–inactivity cycle

Activity can provoke breathlessness. If a person increasingly avoids activity, fitness and muscle strength decline. The same stairs, walk or household task then uses a larger proportion of maximum capacity, so breathlessness arrives sooner and further avoidance becomes tempting (Rochester et al., 2023) (Zhang et al., 2024).

Pulmonary rehabilitation aims to break this cycle. Breathlessness during exercise does not automatically mean that exercise is damaging; people need to learn which breathlessness is expected and controlled and which symptoms are warning signs (Rochester et al., 2023).

Can you still improve?

Yes. Progress usually does not mean that damaged alveoli return. It may mean walking farther, cycling longer, standing up more easily, needing fewer rests or feeling more confident during activity (Rochester et al., 2023).

Systematic reviews show that endurance, resistance and combined programmes can improve functional capacity, exercise tolerance and several measures of quality of life (Zhang et al., 2024).

Your lungs determine part of what is possible, but not everything that can still be trained.

Maintenance can also be valuable. Remaining able to shop or care for yourself is a meaningful outcome even when spirometry does not improve (Rochester et al., 2023).

What is pulmonary rehabilitation?

Pulmonary rehabilitation is an individual programme combining exercise, education and support. The American Thoracic Society strongly recommends it for stable COPD and after hospitalisation for a flare-up (Rochester et al., 2023).

A programme may include endurance and resistance training, COPD education, inhaler instruction, smoking-cessation support, nutrition, breathlessness management, energy conservation and psychological support (Rochester et al., 2023).

Care is matched to the limiting factor. Ventilation may dominate in one person; weakness, low weight, anxiety, heart disease or joint problems may dominate in another (GOLD, 2026).

Endurance and interval training

Endurance work may use walking, cycling, a seated bike, treadmill or adapted arm or leg ergometer. It can improve aerobic capacity, walking performance and daily tolerance (Zhang et al., 2024).

Not everyone can sustain continuous exercise. Interval training alternates shorter work periods with rest or lighter activity. A meta-analysis found effects at least comparable to continuous training, with some outcomes favouring intervals and severe work-period breathlessness potentially being easier to tolerate (Alexiou et al., 2021).

Interval length and intensity should be based on testing, symptoms and recovery; there is no universal programme for all people with COPD (Rochester et al., 2023).

Strength training and muscle weakness

Some people with COPD develop weakness and muscle loss. Inactivity, inflammation, malnutrition, ageing, medication and hospitalisation may contribute (GOLD, 2026).

When leg muscles are weaker, standing and stair climbing use a greater proportion of maximum strength, causing earlier fatigue and breathlessness even without a sudden change in lung function (Zhang et al., 2024).

Both higher-load and low-to-moderate-load resistance training can improve strength. Current evidence does not establish one mandatory protocol, so load, volume and exercise selection should be individualised (Topçuoğlu et al., 2024).

Options include sit-to-stand, leg press, knee extension, hamstring curl, calf raises, rows, chest press and elastic-band exercises. Machines and seated versions may help when balance or prolonged breathlessness limits exercise (Rochester et al., 2023).

Inspiratory muscle training

Some people have measurable weakness of the muscles used to inhale. Training with a dedicated resistance device can improve inspiratory strength and may support breathlessness and quality of life (Han et al., 2024).

This is not the same as performing random breathing exercises. Resistance is prescribed deliberately, and the method is an adjunct for selected patients rather than a replacement for whole-body training, medication or pulmonary rehabilitation (Han et al., 2024).

How hard can you train?

No single intensity is safe and optimal for everyone. Symptoms, exercise testing, oxygen saturation, previous flare-ups, cardiovascular disease, strength, medication and oxygen use all matter (Rochester et al., 2023) (GOLD, 2026).

Complete absence of breathlessness is not always a realistic goal. Pulmonary rehabilitation may deliberately use a demanding but controlled intensity. The old advice “never train when you become breathless” is therefore too broad (Rochester et al., 2023).

The key is distinguishing expected exertional breathlessness from excessive load, a developing flare-up or another medical problem. Initial progression in moderate or severe COPD is best supervised (GOLD, 2026).

Goals at different levels of severity

Mild or moderate limitations

With stable COPD and limited symptoms, goals may include real training progression: longer walking, greater cycling resistance, increased strength and maintaining work or hobbies. Progress remains individual and symptom-guided (Rochester et al., 2023).

More severe limitations

Shorter intervals, longer rests, seated exercises, lower volume and closer oxygen monitoring may be required. Functional improvement is still possible from a low starting capacity (Rochester et al., 2023) (Zhang et al., 2024).

Very severe limitations

Goals may shift towards safe transfers, covering short distances, distributing energy and preserving independence. Maintenance itself may be a relevant outcome (Janssen et al., 2023).

Exercise after a flare-up

During an acute flare-up, medical treatment takes priority. Once stable, prolonged complete inactivity can accelerate loss of muscle and fitness (GOLD, 2026).

The American Thoracic Society recommends pulmonary rehabilitation after hospitalisation for a COPD exacerbation. Rebuilding usually begins below the previous level and follows the individual recovery rate (Rochester et al., 2023).

Training with oxygen

Some people use long-term oxygen or receive supplemental oxygen during exercise. Oxygen is a medical treatment, and the prescribed flow should not be changed without medical instruction (GOLD, 2026).

Exercise can still be valuable with prescribed oxygen. Training should respect personal saturation limits, tubing safety, symptoms and instructions from the respiratory care team (GOLD, 2026).

When should you stop or seek help?

Stop and assess the situation if breathlessness is suddenly much worse than normal, there is chest pain or pressure, near-fainting, new confusion, blue lips, coughing blood or an oxygen reading outside personally agreed limits (GOLD, 2026).

Severe breathlessness at rest, loss of consciousness, confusion or blue discolouration requires urgent medical help. Worsening breathlessness, cough or sputum over hours or days may indicate a flare-up and should be managed according to the individual action plan (Celli et al., 2021) (GOLD, 2026).

Can COPD be slowed or reversed?

COPD cannot currently be fully reversed. Exercise and inhaled medication do not regrow destroyed alveoli (Agustí et al., 2023).

Treatment can reduce symptoms, help prevent flare-ups, enable activity and support quality of life (GOLD, 2026).

For people who smoke, cessation is one of the most important modifiable steps. A recent meta-analysis associated cessation with more favourable lung-function indicators, fewer symptoms and better exercise tolerance; the authors cautiously described mortality as potentially improved (Wang et al., 2024).

Realistic hope is therefore not limited to regrowing lung tissue. It may mean fewer attacks, better daily capacity and longer independence (Rochester et al., 2023).

New and experimental treatments

Lung-volume reduction

In carefully selected people with severe emphysema and marked hyperinflation, bronchoscopic lung-volume reduction may be considered. Severely damaged, overinflated regions can be closed with valves so that other lung regions and respiratory muscles work more efficiently (Zhang et al., 2024).

Comparative evidence shows improvements in lung function, walking distance, breathlessness and quality of life in selected patients, but more adverse events than medical care alone. It is not a cure and does not suit every COPD phenotype (Zhang et al., 2024).

Targeted medicines

COPD includes different biological patterns. New targeted drugs are used or investigated in specific groups mainly to reduce flare-ups. Selection depends on characteristics such as inflammatory profile and clinical history, and these treatments do not regrow lost lung tissue (GOLD, 2026).

Stem cells and regenerative medicine

Stem-cell therapy is being investigated because mesenchymal stem cells may influence inflammation and repair pathways. It remains experimental: there is no convincing evidence for a clinically proven treatment that reverses COPD or sustainably restores damaged lung function (Lai et al., 2024).

Commercial stem-cell treatment should therefore not be presented as a proven alternative to standard COPD care (Lai et al., 2024).

Living with advanced COPD

In advanced COPD, becoming progressively fitter or stronger may no longer be the main goal. Palliative care can be integrated alongside active COPD treatment and focuses on symptoms, comfort, quality of life, personal wishes and support for loved ones (Janssen et al., 2023).

Palliative care does not automatically mean the final days of life. European guidance recommends needs-based support rather than waiting for a precise survival prediction (Janssen et al., 2023).

When almost no physical reserve remains, a few steps to a chair or sitting outside may be enough exertion. Comfort, family, friends, faith, music, conversation and small meaningful moments may then matter more than training progression.

Conclusion

COPD is a chronic lung disease that cannot currently be fully cured. Exercise does not restore damaged alveoli and does not replace medical care (Agustí et al., 2023).

But that is not the end of the story. Pulmonary rehabilitation, endurance work and strength training can improve exercise capacity, strength, breathlessness, daily function and quality of life (Rochester et al., 2023) (Zhang et al., 2024) (Topçuoğlu et al., 2024).

Appropriate goals differ by person and phase. Earlier, real training progression may be possible. Later, preserving independence may become more important. In advanced illness, comfort and meaningful time with loved ones may outweigh physical performance (Janssen et al., 2023).

Related reading